Biopta Ltd, Glasgow, UK-based life science firm that develops new drugs has secured £265,000 in a second round of funding.
Investors include Braveheart Investment Group, TRI Cap, the Scottish Co-Investment Fund and the company’s board of directors.
The company, which was spun-out from Glasgow Caledonian University in 2002, will use the funds to expand its research and development of its human tissue testing techniques. Biopta uses donated, residual human tissue collected from surgery to conduct non-clinical trials on new drugs.
Biopta had raised £900,000 in December 2008 from the same group of investors.